Brief: Hofseth Biocare Gets Approval From Health Canada For Qualified Health Claims For Its Salmon Protein Hydrolysate
Oct 19 (Reuters) - Hofseth Biocare ASA HOFS.OL :
* GETS APPROVAL FROM HEALTH CANADA FOR QUALIFIED HEALTH
CLAIMS
(QHCS) FOR ITS SALMON PROTEIN HYDROLYSATE (PROGO AND COLLAGO)
* HBC CAN NOW SELL PROGO® AND COLLAGO® ACROSS WHOLE OF NORTH
AMERICA
* FURTHERMORE, HEALTH CANADA'S QHCS ARE INTERNATIONALLY
RECOGNIZED
BY MOST ASIAN COUNTRIES
Source text for Eikon: ID:nGNE4dy5KX
Further company coverage: HOFS.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering